A New Paradigm In Cancer Management

Nometics Inc. is a private specialty pharmaceutical company that is focussed on the treatment of cancer through the restoration of the nitric oxide signalling pathway.

Nometics Inc. has demonstrated success ‘in the clinic’.  Our lead product, NOVade™, addresses hypoxia in cancer – a condition in locally advanced tumours that causes disease progression through metastasis, increased invasiveness and resistance to treatment.

With a novel mode of action that is delivered via a transdermal patch with no adverse effects, Nometics Inc. offers a ‘new paradigm in cancer management’.